http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—Although women diagnosed with ovarian cancer who carry a BRCA gene mutation have a short-term survival advantage, this benefit is not reflected in the long-term, according to a new study. http://medicalxpress.com/news/2013-02-gene-mutation-benefit-ovarian-cancer.html Cancer Wed, 20 Feb 2013 03:40:02 EST news280552931 Women with harmful mutations in the BRCA gene, which put them at higher risk of developing breast and ovarian cancer, tend to undergo menopause significantly sooner than other women, allowing them an even briefer reproductive window and possibly a higher risk of infertility, according to a study led by researchers at UC San Francisco. http://medicalxpress.com/news/2013-01-early-menopause-women-brca-gene.html Cancer Tue, 29 Jan 2013 00:20:01 EST news278613483 Women who inherit the cancer genes BRCA1 or BRCA2 from their paternal lineage may get a diagnosis a decade earlier than those women who carry the cancer genes from their mother and her ancestors, according to a new study by researchers at the North Shore-LIJ Health System's Monter Cancer Center in Lake Success, NY. The findings were reported on Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium. http://medicalxpress.com/news/2011-12-gene-inheritance-patterns-age-diagnosis.html Cancer Mon, 12 Dec 2011 09:31:44 EST news242904694 Ovarian cancer is a rare but often deadly disease that can strike at any time in a woman's life. It affects one in 70 women and in the past was referred to as a silent killer, but researchers have found there are symptoms associated with ovarian cancer that can assist in early detection. Experts at Northwestern Memorial say the best defense is to make use of preventive methods, understand the risks and recognize potential warning signs of ovarian cancer. http://medicalxpress.com/news/2011-09-early-key-ovarian-cancer.html Cancer Thu, 15 Sep 2011 16:10:36 EST news235321718 Women with a deleterious gene mutation are diagnosed with breast cancer almost eight years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas MD Anderson Cancer Center. http://medicalxpress.com/news/2011-09-women-inherit-brca-gene-mutations.html Cancer Mon, 12 Sep 2011 03:08:08 EST news235015676 The PARP inhibitor, olaparib, that has shown promise in women with an inherited mutation in their BRCA1 or BRCA2 gene (accounting for about 5-10% of breast and ovarian cancer cases), has, for the first time, been shown to reduce the size of tumours in a much wider group of ovarian cancer patients without these BRCA gene mutations. The findings, published Online First in The Lancet Oncology, highlight the potential of olaparib to treat patients with more common sporadic (non-hereditary) tumours and could offer a new treatment option for one of the most deadly cancers in women. http://medicalxpress.com/news/2011-08-olaparib-ovarian-cancer-brca-mutations.html Cancer Sun, 21 Aug 2011 18:30:02 EST news233152706 New research aimed to better identify the genetic factors that lead to breast cancer has uncovered a link between the fat mass and obesity associated gene (FTO) and a higher incidence of breast cancer. According to the study conducted at Northwestern Memorial Hospital, people who possess a variant of the FTO gene have up to a 30 percent greater chance of developing breast cancer. Research to identify why the link exists is ongoing, but experts say the finding takes us one step closer to personalized medicine based on genetic risk which would allow for better monitoring and prevention of illness, as well as targeted treatment. http://medicalxpress.com/news/2011-05-link-obesity-gene-breast-cancer.html Cancer Mon, 23 May 2011 11:36:52 EST news225369396